1. Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer;Janmaat;Cochrane Database Syst Rev,2017
2. The efficacy and safety of first-line chemotherapy in advanced esophagogastric cancer: a network meta-analysis;Ter Veer;J Natl Cancer Inst,2016
3. Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature;Ter Veer;Cancer Metastasis Rev,2016
4. Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancer;Davidson;World J Gastrointest Oncol,2017
5. The phase 3 KEYNOTE-181 study: pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer;Metges;Ann Oncol,2019